Assessing Omega-3 Therapy and Its Cardiovascular Benefits: What About Icosapent Ethyl? A Systematic Review and Meta-Analysis

<b>Background:</b> Lipid-lowering therapies are an option for stabilizing lipid levels. Icosapent ethyl (IPE) is a highly purified formulation of eicosapentaenoic acid, which can reduce lipid action, improve plaque stabilization, reduce platelet aggregation, lower TG, and prevent cardiovascular even...

全面介紹

書目詳細資料

Principais autores:	Nathália Mendes Machado, Maria Vitória Barroso Oliveira, Karina Quesada, Jesselina Francisco dos Santos Haber, Ricardo José Tofano, Claudio José Rubira, Tereza Lais Menegucci Zutin, Rosa Direito, Eliana de Souza Bastos Mazuqueli Pereira, Camila Marcondes de Oliveira, Ricardo de Alvares Goulart, Vitor Engrácia Valenti, Kátia Portero Sloan, Lance Alan Sloan, Lucas Fornari Laurindo, Sandra Maria Barbalho
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2025-04-01
叢編:	Pharmaceuticals
主題:	Icosapent ethyl eicosapentaenoic acid EPA lipid-lowering therapies lipids cardiovascular diseases
在線閱讀:	https://www.mdpi.com/1424-8247/18/4/601
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!